
| Ïðåçèäåíò Óêðàèíû âàêöèíèðîâàëñÿ ïðîòèâ êîðîíàâèðóñà ïðåïàðàòîì Covishield, ðàçðàáîòàííûì àíãëî-øâåäñêîé êîìïàíèåé AstraZeneca ñîâìåñòíî ñ Îêñôîðäñêèì óíèâåðñèòåòîì |
Ïðåçèäåíò Óêðàèíû âàêöèíèðîâàëñÿ ïðîòèâ êîðîíàâèðóñà ïðåïàðàòîì Covishield, ðàçðàáîòàííûì àíãëî-øâåäñêîé êîìïàíèåé AstraZeneca ñîâìåñòíî ñ Îêñôîðäñêèì óíèâåðñèòåòîì
Èñòî÷íèê: mail.ru
| Âðåìÿ çàãðóçêè ñòðàíèöû 0.275 ñåê. |
Õîñòèíã - Ðàçðàáîòêà - Ñîïðîâîæäåíèå. Copyright © 2007-2015 All Rights Reserved |